COVID-19 vaccine acceptance and hesitancy in Indian context: a systematic review and meta-analysis.

COVID-19 India associated factors review vaccine acceptance vaccine hesitancy

Journal

Pathogens and global health
ISSN: 2047-7732
Titre abrégé: Pathog Glob Health
Pays: England
ID NLM: 101583421

Informations de publication

Date de publication:
20 Nov 2023
Historique:
medline: 28 11 2023
pubmed: 28 11 2023
entrez: 28 11 2023
Statut: aheadofprint

Résumé

Vaccination against COVID-19 is vital for achieving herd immunity, and the Government of India has adopted several strategies to achieve coverage. Vaccine hesitancy was identified as a potential obstacle in combating COVID-19. This study aimed to review the COVID-19 vaccine acceptance and hesitancy, and factors associated with vaccine hesitancy based on studies conducted in Indian populations. The data sources (PubMed, Scopus, and Google Scholar) were searched by following PRISMA guidelines, and the search was done in September 2022. We performed a meta-analysis through a random effect model to estimate pooled hesitancy rate with 95% confidence intervals (CI). A total of 3,339 records were searched, of which 46 studies were found to be eligible for inclusion in the review. The included studies covered 65,551 respondents, 55% were female. Studies reported COVID-19 vaccine acceptance rate of 65.7% in January-February 2021, which increased to 92.8% in May-August 2021. Likewise, the rate of vaccine hesitancy in December 2020 was 37%, dropping to 12.1% through November 2021. The estimated pooled COVID-19 vaccine hesitancy was 31% [95% CI: 27% - 36%, I

Identifiants

pubmed: 38014567
doi: 10.1080/20477724.2023.2285184
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-14

Auteurs

Sangeeta Dey (S)

Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.

Yadlapalli S Kusuma (YS)

Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.

Shashi Kant (S)

Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.

Dewesh Kumar (D)

Department of Preventive and Social Medicine, Rajendra Institute of Medical Sciences, Ranchi, India.

Retheesh Babu Gopalan (RB)

ICMR-National Institute of Virology, Kerala Unit, Alappuzha, India.

Parikipandla Sridevi (P)

Department of Biotechnology, Central Tribal University of Andhra Pradesh, Vizianagaram, India.

Sumit Aggarwal (S)

Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India.

Classifications MeSH